Biogen Exercises Option To Acquire TMS-007 For Acute Ischemic Stroke

WESTON (dpa-AFX) - Neuroscience company Biogen Inc (BIIB) announced Wednesday that it has exercised its option to acquire TMS-007, an investigational drug for acute ischemic stroke, from privately-held

Related Keywords

Japan ,Japanese , ,Co Ltd ,Biogen Inc ,Biogen ,Exercises ,Option ,Cquire ,Cute ,Ischemic ,Stroke ,ஜப்பான் ,ஜப்பானிய ,இணை லிமிடெட் ,பயோஜென் இன்க் ,பயோஜென் ,அழகான ,